Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PNTG Stock Forecast 2026-2027
$28.82
Current Price
$996.99M
Market Cap
Buy 7
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to PNTG Price Targets
+38.8%
To High Target of $40.00
+30.1%
To Median Target of $37.50
+18.0%
To Low Target of $34.00
PNTG Price Momentum
-1.0%
1 Week Change
-3.1%
1 Month Change
+3.8%
1 Year Change
+2.4%
Year-to-Date Change
-5.4%
From 52W High of $30.46
+36.1%
From 52W Low of $21.18
📊 TOP ANALYST CALLS
Did PNTG Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Pennant Group is one of their latest high-conviction picks.
Latest PNTG Stock Price Targets & Analyst Predictions
Based on our analysis of 13 Wall Street analysts, PNTG has a bullish consensus with a median price target of $37.50 (ranging from $34.00 to $40.00). The overall analyst rating is Strong Buy (9.7/10). Currently trading at $28.82, the median forecast implies a 30.1% upside. This outlook is supported by 7 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Raj Kumar at Stephens & Co., projecting a 38.8% upside. Conversely, the most conservative target is provided by David Macdonald at Truist Securities, suggesting a 18.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PNTG Analyst Ratings
7
Buy
0
Hold
0
Sell
PNTG Price Target Range
Low
$34.00
Average
$37.50
High
$40.00
Current: $28.82
Latest PNTG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PNTG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 7, 2026 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $38.00 |
| Dec 8, 2025 | William Blair | Jared Haase | Outperform | Initiates | $N/A |
| Dec 2, 2025 | Truist Securities | David Macdonald | Buy | Upgrade | $34.00 |
| Nov 18, 2025 | Wells Fargo | Stephen Baxter | Overweight | Upgrade | $31.00 |
| Nov 17, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $39.00 |
| Oct 24, 2025 | Jefferies | Brian Tanquilut | Buy | Initiates | $30.00 |
| Oct 9, 2025 | Stephens & Co. | Raj Kumar | Overweight | Reiterates | $40.00 |
| Sep 4, 2025 | Stephens & Co. | Raj Kumar | Overweight | Reiterates | $40.00 |
| Aug 14, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $29.00 |
| Jul 16, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $28.00 |
| Jun 10, 2025 | Stephens & Co. | Raj Kumar | Overweight | Reiterates | $35.00 |
| Jun 3, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $31.00 |
| May 12, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $32.00 |
| Apr 2, 2025 | Stephens & Co. | Raj Kumar | Overweight | Reiterates | $38.00 |
| Mar 11, 2025 | Stephens & Co. | Scott Fidel | Overweight | Reiterates | $38.00 |
| Mar 7, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $28.00 |
| Jan 6, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $32.00 |
| Dec 19, 2024 | Wells Fargo | Equal-Weight | Initiates | $33.00 | |
| Nov 8, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $37.00 |
| Oct 23, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $38.00 |
The Pennant Group, Inc. (PNTG) Competitors
The following stocks are similar to Pennant Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
PNTG
Pennant Group
mkt cap
973.12M
The Pennant Group, Inc. (PNTG) Financial Data
The Pennant Group, Inc. has a market capitalization of $996.99M with a P/E ratio of 38.3x. The company generates $847.27M in trailing twelve-month revenue with a 3.2% profit margin.
Revenue growth is +26.8% quarter-over-quarter, while maintaining an operating margin of +4.4% and return on equity of +11.3%.
Valuation Metrics
Market Cap
$996.99M
Enterprise Value
$1.33B
P/E Ratio
38.3x
PEG Ratio
-3.8x
Price/Sales
1.2x
Growth & Margins
Revenue Growth (YoY)
+26.8%
Gross Margin
+13.8%
Operating Margin
+4.4%
Net Margin
+3.2%
EPS Growth
-2.0%
Financial Health
Cash/Price Ratio
+0.2%
Current Ratio
1.0x
Debt/Equity
90.0x
ROE
+11.3%
ROA
+3.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
The Pennant Group, Inc. (PNTG) Business Model
About The Pennant Group, Inc.
What They Do
Provides post-acute healthcare services in the U.S.
Business Model
The company generates revenue by operating home health and hospice agencies, as well as senior living communities. Their decentralized service model allows local leadership to customize care, which enhances community engagement and meets specific local needs.
Additional Information
Pennant Group, Inc. plays a significant role in the continuum of care for the elderly, particularly for those needing specialized support post-hospitalization. As the aging population grows, the demand for their services is expected to increase, positioning the company favorably in the healthcare market.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
7,000
CEO
Mr. Brent J. Guerisoli
Country
United States
IPO Year
N/A
Website
pennantgroup.comThe Pennant Group, Inc. (PNTG) Latest News & Analysis
Latest News
Quick Summary
The Zacks Medical - Outpatient and Home Healthcare industry is expected to grow due to an aging population and increased AI adoption, benefiting companies like EHC, DVA, OPCH, and PNTG.
Why It Matters
An aging population and increased AI use suggest strong growth for outpatient and home healthcare, benefiting companies like EHC, DVA, OPCH, and PNTG, which could enhance investor returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Pennant Group, Inc. (PNTG) has reached a key support level, with its 50-day moving average recently crossing above the 200-day moving average, indicating a potential bullish trend.
Why It Matters
The golden cross indicates potential bullish momentum for PNTG, suggesting increased investor interest and possible upward price movement, making it a notable stock to monitor.
Source: Zacks Investment Research
Market Sentiment:
Positive
Does The Pennant Group (PNTG) Have the Potential to Rally 30.69% as Wall Street Analysts Expect?
2 months ago
Quick Summary
Wall Street analysts' average price target for The Pennant Group (PNTG) suggests a potential upside of 30.7%, supported by positive earnings estimate revisions.
Why It Matters
The 30.7% upside in price targets suggests strong growth potential for The Pennant Group (PNTG), while positive earnings revisions could further boost investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Pennant Group, Inc. will hold its Q3 2025 earnings call on November 6, 2025, at 12 PM EST, featuring key executives including the CEO and CFO.
Why It Matters
The earnings call provides insights into The Pennant Group's financial performance and strategic direction, impacting investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
The Pennant Group, Inc. (NASDAQ: PNTG) has announced two acquisitions aimed at enhancing its market presence in home health, hospice, home care, and senior living sectors.
Why It Matters
The Pennant Group's acquisitions enhance market presence, potentially boosting revenue and market share, signaling growth and stability that can attract investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
The Pennant Group, Inc. (PNTG) reported Q3 earnings of $0.30 per share, exceeding the Zacks Consensus Estimate of $0.29, and up from $0.26 per share in the same quarter last year.
Why It Matters
The Pennant Group's earnings beat estimates and show year-over-year growth, indicating financial strength and potential for stock price appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About PNTG Stock
What is The Pennant Group, Inc.'s (PNTG) stock forecast for 2026?
Based on our analysis of 13 Wall Street analysts, The Pennant Group, Inc. (PNTG) has a median price target of $37.50. The highest price target is $40.00 and the lowest is $34.00.
Is PNTG stock a good investment in 2026?
According to current analyst ratings, PNTG has 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $28.82. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PNTG stock?
Wall Street analysts predict PNTG stock could reach $37.50 in the next 12 months. This represents a 30.1% increase from the current price of $28.82. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is The Pennant Group, Inc.'s business model?
The company generates revenue by operating home health and hospice agencies, as well as senior living communities. Their decentralized service model allows local leadership to customize care, which enhances community engagement and meets specific local needs.
What is the highest forecasted price for PNTG The Pennant Group, Inc.?
The highest price target for PNTG is $40.00 from Raj Kumar at Stephens & Co., which represents a 38.8% increase from the current price of $28.82.
What is the lowest forecasted price for PNTG The Pennant Group, Inc.?
The lowest price target for PNTG is $34.00 from David Macdonald at Truist Securities, which represents a 18.0% increase from the current price of $28.82.
What is the overall PNTG consensus from analysts for The Pennant Group, Inc.?
The overall analyst consensus for PNTG is bullish. Out of 13 Wall Street analysts, 7 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $37.50.
How accurate are PNTG stock price projections?
Stock price projections, including those for The Pennant Group, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 15, 2026 4:01 AM UTC